Yi Kong
8PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 29, 2024
Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency.Panpan Chen, Cai Chen, Yizheng Zheng
|Feb 28, 2022
Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors.Ningning Yao, Zhiping Jia, Yongbin Tian
|Dec 24, 2021
WPK5, a Novel Kunitz-Type Peptide from the Leech Whitmania pigra Inhibiting Factor XIa, and Its Loop-Replaced Mutant to Improve Potency.Yi-Zheng Zheng, Xiao-Ru Ji, Yun-Yang Liu
|Oct 23, 2021
DAKS1, a Kunitz Scaffold Peptide from the Venom Gland of Deinagkistrodon acutus Prevents Carotid-Artery and Middle-Cerebral-Artery Thrombosis via Targeting Factor XIa.Zhiping Jia, Yunyang Liu, Xiaoru Ji
|Aug 18, 2018
Purification and Characterization of a Novel Antiplatelet Peptide from Deinagkistrodon acutus Venom.Yi Kong, Qing Sun, Qi Zhao
|Aug 08, 2018
A Short Half-Life αIIbβ₃ Antagonist ANTP266 Reduces Thrombus Formation.Tong-Dan Liu, Shen-Hong Ren, Xue Ding
Pageof 2
